We have located links that may give you full text access.
Case Reports
Journal Article
Review
Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.
Medicine (Baltimore) 2018 June
RATIONALE: Hepatic vein occlusive disease (HVOD) is a rare complication after liver transplantation, which is characterized by nonthrombotic, fibrous obliteration of the small centrilobular hepatic veins by connective tissue and centrilobular necrosis in zone 3 of the acini. HVOD after solid organ transplantation has been reported; recently, most of these reports with limited cases have documented that acute cell rejection and immunosuppressive agents are the major causative factors. HVOD is relatively a rare complication of liver transplantation with the incidence of approximately 2%.
PATIENT CONCERNS: A 59-year-old male patient with alcoholic liver cirrhosis underwent liver transplantation in our center. He suffered ascites, renal impairment 3 months after the surgery while liver enzymes were in normal range.
DIAGNOSES: Imagining and pathology showed no evidence of rejection or vessels complications. HVOD was diagnosed with pathology biopsy.
INTERVENTIONS: Tacrolimus was withdrawn and the progression of HVOD was reversed.
OUTCOMES: Now, this patient has been followed up for 6 months after discharge with normal liver graft function.
LESSONS: The use of tacrolimus in patients after liver transplantation may cause HVOD. Patients with jaundice, body weight gain, and refractory ascites should be strongly suspected of tacrolimus related HVOD.
PATIENT CONCERNS: A 59-year-old male patient with alcoholic liver cirrhosis underwent liver transplantation in our center. He suffered ascites, renal impairment 3 months after the surgery while liver enzymes were in normal range.
DIAGNOSES: Imagining and pathology showed no evidence of rejection or vessels complications. HVOD was diagnosed with pathology biopsy.
INTERVENTIONS: Tacrolimus was withdrawn and the progression of HVOD was reversed.
OUTCOMES: Now, this patient has been followed up for 6 months after discharge with normal liver graft function.
LESSONS: The use of tacrolimus in patients after liver transplantation may cause HVOD. Patients with jaundice, body weight gain, and refractory ascites should be strongly suspected of tacrolimus related HVOD.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app